1. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115-32. doi:10.3322/caac.21338.
2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. doi:10.3322/caac.21492.
3. Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol. 2019;14(1):26-38. doi:10.5114/pg.2018.80001.
4. Olefson S, Moss SF. Obesity and related risk factors in gastric cardia adenocarcinoma. Gastric Cancer. 2015;18(1):23-32. doi:10.1007/s10120-014-0425-4.
5. Jia J, Zhang X, Zhan D, Li J, Li Z, Li H, et al. LncRNA H19 interacted with miR-130a-3p and miR-17-5p to modify radio-resistance and chemo-sensitivity of cardiac carcinoma cells. Cancer Med. 2019;8(4):1604-18. doi:10.1002/cam4.1860.
6. Xu H, Zhang L, Miao J, Liu S, Liu H, Jia T, et al. Patterns of recurrence in adenocarcinoma of the esophagogastric junction: a retrospective study. World J Surg Oncol. 2020;18(1):144. doi:10.1186/s12957-020-01917-5.
7. Cao J, Yang T, Wang G, Zhang H, You Y, Chen J, et al. Analysis of the clinicopathological features and prognostic factors in 734 cases of Chinese Hui and Han patients with adenocarcinoma of the esophagogastric junction. Surg Oncol. 2018;27(3):556-62. doi:10.1016/j.suronc.2018.07.008.
8. Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Corvera C, Das P, et al. Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019;17(7):855-83. doi:10.6004/jnccn.2019.0033.
9. Ma RM, Yang F, Huang DP, Zheng M, Wang YL. The Prognostic Value of the Expression of SMC4 mRNA in Breast Cancer. Dis Markers. 2019;2019(:2183057. doi:10.1155/2019/2183057.
10. Peng L, Tang Y, Zhang Y, Guo S, Peng L, Ye L, et al. Structural maintenance of chromosomes 4 is required for leukemia stem cell maintenance in MLL-AF9 induced acute myeloid leukemia. Leuk Lymphoma. 2018;59(10):2423-30. doi:10.1080/10428194.2017.1387906.
11. Zhou B, Yuan T, Liu M, Liu H, Xie J, Shen Y, et al. Overexpression of the structural maintenance of chromosome 4 protein is associated with tumor de-differentiation, advanced stage and vascular invasion of primary liver cancer. Oncol Rep. 2012;28(4):1263-8. doi:10.3892/or.2012.1929.
12. Feng XD, Song Q, Li CW, Chen J, Tang HM, Peng ZH, et al. Structural maintenance of chromosomes 4 is a predictor of survival and a novel therapeutic target in colorectal cancer. Asian Pac J Cancer Prev. 2014;15(21):9459-65. doi:10.7314/apjcp.2014.15.21.9459.
13. Zhang C, Kuang M, Li M, Feng L, Zhang K, Cheng S. SMC4, which is essentially involved in lung development, is associated with lung adenocarcinoma progression. Sci Rep. 2016;6(:34508. doi:10.1038/srep34508.
14. Jiang L, Zhou J, Zhong D, Zhou Y, Zhang W, Wu W, et al. Overexpression of SMC4 activates TGFβ/Smad signaling and promotes aggressive phenotype in glioma cells. Oncogenesis. 2017;6(3):e301. doi:10.1038/oncsis.2017.8.
15. Abdi E, Latifi-Navid S, Zahri S, Yazdanbod A, Pourfarzi F. Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectives. Cancer Med. 2019;8(13):6114-26. doi:10.1002/cam4.2497.
16. Chevallay M, Bollschweiler E, Chandramohan SM, Schmidt T, Koch O, Demanzoni G, et al. Cancer of the gastroesophageal junction: a diagnosis, classification, and management review. Ann N Y Acad Sci. 2018;1434(1):132-8. doi:10.1111/nyas.13954.
17. Chen Y, Huang F, Deng L, Yuan X, Tao Q, Wang T, et al. HIF-1-miR-219-SMC4 Regulatory Pathway Promoting Proliferation and Migration of HCC under Hypoxic Condition. Biomed Res Int. 2019;2019(:8983704. doi:10.1155/2019/8983704.
18. Zhou J, Wu G, Tong Z, Sun J, Su J, Cao Z, et al. Prognostic relevance of SMC family gene expression in human sarcoma. Aging (Albany NY). 2020;13(1):1473-87. doi:10.18632/aging.202455.
19. Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20(2):69-84. doi:10.1038/s41580-018-0080-4.
20. Santamaria PG, Moreno-Bueno G, Portillo F, Cano A. EMT: Present and future in clinical oncology. Mol Oncol. 2017;11(7):718-38. doi:10.1002/1878-0261.12091.
21. Zhang Y, Weinberg RA. Epithelial-to-mesenchymal transition in cancer: complexity and opportunities. Front Med. 2018;12(4):361-73. doi:10.1007/s11684-018-0656-6.
22. Zhang X, Zhu M, Wang H, Song Z, Zhan D, Cao W, et al. Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway. Gene. 2021;766(:145163. doi:10.1016/j.gene.2020.145163.
23. Taciak B, Pruszynska I, Kiraga L, Bialasek M, Krol M. Wnt signaling pathway in development and cancer. J Physiol Pharmacol. 2018;69(2). doi:10.26402/jpp.2018.2.07.
24. Shang S, Hua F, Hu ZW. The regulation of β-catenin activity and function in cancer: therapeutic opportunities. Oncotarget. 2017;8(20):33972-89. doi:10.18632/oncotarget.15687.
25. Tian S, Peng P, Li J, Deng H, Zhan N, Zeng Z, et al. SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway. Aging (Albany NY). 2020;12(4):3574-93. doi:10.18632/aging.102831.
26. Wang J, Cai H, Liu Q, Xia Y, Xing L, Zuo Q, et al. Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/β-Catenin Signaling Pathway and EMT. Am J Chin Med. 2020;48(3):703-18. doi:10.1142/S0192415X20500354.